|
Company Snapshot
| COMPANY INFORMATION |
| Advitech Inc. |
|
|
140-1165 boul Lebourgneuf
Québec, QC
G2K 2C9
Tel:
(418)
686-7498
Fax:
(418)
686-2446 |
Contact Name
Michael Stangel |
Industry
Biotechnology |
|
|
Key Executives
Michael Stangel, CEO
|
Researches, develops and commercializes nutraceutical ingredients and products to prevent immune-mediated inflammatory disorders. |
|
|
|
|
|
TOP INDUSTRY PLAYERS
|
|
(Links are to Snapshots.) |
|
| |
| FINANCIAL RATIOS AS OF FEB 8/10 |
| Listed |
Close |
52-wk
High |
52-wk
Low |
IAD |
Latest
Dividend |
Yield |
60-mo
Beta |
| TSX-VEN/AVI |
$0.07 |
$0.36 |
$0.04 |
n.a. |
n.a. |
n.a. |
1.32 |
Avg 20-day
Volume |
P/E |
12-mo
EPS |
EPS
Date |
1-yr
Return |
3-yr
Return |
5-yr
Return |
Market
Cap. (000s) |
| 8,888 |
n.a. |
$-0.06 |
Sept. 30/09 |
-45.83%
|
-60.31%
|
-44.19%
|
$4,749 |
|
| |
| ANNUAL FINANCIALS |
| Periods ended: |
12m Dec. 31/08 |
12m Dec. 31/07 |
12m Dec. 31/06 |
|
$000s |
$000s |
$000s |
| Operating revenue |
1,063 |
1,110 |
661 |
| Net income |
(1,539) |
(1,350) |
(1,375) |
| Total assets |
1,416 |
2,242 |
1,237 |
|
$ |
$ |
$ |
| Earnings per share* |
(0.17) |
(0.16) |
(0.16) |
| |
| * Common |
|
|
|
COMPANY NEWS
|
Results for 'Advitech Inc.' from past 30 days:
No hits.
(Links are to articles.) |
|
Printer Friendly
